End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
11.31 CNY | +2.17% | +3.38% | +1.25% |
Feb. 20 | Meheco's Unit Gets Nod to Raise Specifications for Piperacillin Sodium for Injection | MT |
Feb. 20 | Argatroban Injection of Meheco's Subsidiary Passes Chinese Drug Regulator's Evaluation | MT |
Sales 2021 | 36.23B 5.01B | Sales 2022 | 37.59B 5.19B | Capitalization | 25.77B 3.56B |
---|---|---|---|---|---|
Net income 2021 | 647M 89.39M | Net income 2022 | 736M 102M | EV / Sales 2021 | 0.4 x |
Net Debt 2021 | 1.88B 260M | Net Debt 2022 | 1.09B 151M | EV / Sales 2022 | 0.71 x |
P/E ratio 2021 |
19.5
x | P/E ratio 2022 |
35
x | Employees | 8,313 |
Yield 2021 |
1.54% | Yield 2022 |
0.86% | Free-Float | 44.6% |
1 day | +2.17% | ||
1 week | +3.38% | ||
Current month | +2.72% | ||
1 month | +0.09% | ||
3 months | +5.31% | ||
6 months | -9.81% | ||
Current year | +1.25% |
Managers | Title | Age | Since |
---|---|---|---|
Hui Dong Hu
CEO | Chief Executive Officer | 48 | 21-09-29 |
Members of the board | Title | Age | Since |
---|---|---|---|
Xin Min Zhang
BRD | Director/Board Member | 62 | 22-08-17 |
Yong Qiang
CHM | Chairman | 58 | 09-09-14 |
Shao Feng Zhang
BRD | Director/Board Member | 46 | Dec. 20 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.47% | 2 M€ | -20.08% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-04-16 | 11.31 | +2.17% | 33 553 570 |
24-04-16 | 11.07 | +2.50% | 37,024,470 |
24-04-15 | 10.8 | +2.18% | 13,252,970 |
24-04-12 | 10.57 | -1.31% | 7,995,065 |
24-04-11 | 10.71 | -0.28% | 5,709,386 |
End-of-day quote Shanghai S.E., April 16, 2024
More quotes1st Jan change | Capi. | |
---|---|---|
+1.25% | 2.29B | |
+13.59% | 69.43B | |
+5.67% | 26.07B | |
+5.02% | 7.98B | |
-2.98% | 7.79B | |
-27.52% | 7.13B | |
+0.18% | 4.52B | |
+21.54% | 4.39B | |
-2.45% | 3.98B | |
-4.54% | 3.82B |
- Stock Market
- Equities
- 600056 Stock